Cargando…

Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia

INTRODUCTION: The role of matrix metalloproteinases (MMPs) in type 2 diabetes mellitus (DM) is not clear as increased activation of MMPs in the vasculature contrasts with decreased activity of MMPs in the kidneys, contributing to development of nephropathy. MATERIAL AND METHODS: We measured serum MM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Krzysztof C., Banach, Ewa, Bieńkiewicz, Małgorzata, Lewiński, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2011
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258712/ https://www.ncbi.nlm.nih.gov/pubmed/22291770 http://dx.doi.org/10.5114/aoms.2011.22081

Ejemplares similares

Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin
por: Lewiński, Andrzej, et al.
Publicado: (2013)

Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1
por: Lewinski, Andrzej, et al.
Publicado: (2013)

Cigarette Smoking and Hyperglycaemia in Diabetic Patients
por: Sari, Mutiara Indah, et al.
Publicado: (2018)

Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients
por: Setyopranoto, Ismail, et al.
Publicado: (2018)

Matrix metalloproteinases in subjects with type 1 diabetes
por: Gharagozlian, Sedegheh, et al.
Publicado: (2009)

Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy
por: Kłysik, Anna B., et al.
Publicado: (2010)

Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II
por: Vitlianova, Katerina, et al.
Publicado: (2015)

In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis
por: Lewiński, A, et al.
Publicado: (2012)

The Effect of Autologous Platelet-Rich Gel on the Dynamic Changes of the Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Expression in the Diabetic Chronic Refractory Cutaneous Ulcers
por: Li, Lan, et al.
Publicado: (2015)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Transient hyperglycaemia – an underestimated problem of paediatric oncohaematology
por: Irga, Ninela, et al.
Publicado: (2012)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
por: Yürük Yıldırım, Zeynep, et al.
Publicado: (2019)

The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes
por: Levy, Brian L, et al.
Publicado: (2016)

Hyperglycaemia, glycosuria and ketonuria may not be diabetes.
por: Gray, J., et al.
Publicado: (2003)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Metformin paradoxically worsens insulin resistance in SHORT syndrome
por: Lewandowski, Krzysztof C., et al.
Publicado: (2019)

Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes
por: McNeilly, Alison D., et al.
Publicado: (2023)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
por: Matthews, Jennifer, et al.
Publicado: (2021)

Glucocorticoid‐induced hyperglycaemia and diabetes: Call for action
por: Golubic, Rajna, et al.
Publicado: (2022)

Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
por: Barker, Hannah L., et al.
Publicado: (2023)

Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia
por: Rhou, Yoon Ji J, et al.
Publicado: (2022)

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes
por: Magri, Caroline Jane, et al.
Publicado: (2018)

The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes
por: Su, Jian-bin, et al.
Publicado: (2017)

Plasma Brain Natriuretic Peptide, Endothelin-1, and Matrix Metalloproteinase 9 Expression and Significance in Type 2 Diabetes Mellitus Patients with Ischemic Heart Disease
por: Ju, Chunfang, et al.
Publicado: (2015)

Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease
por: Tuttle, Katherine R., et al.
Publicado: (2020)

Study of matrix metalloproteinases and their inhibitors in breast cancer
por: Vizoso, F J, et al.
Publicado: (2007)

The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus
por: Shin, Dong-Seok, et al.
Publicado: (2010)

Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats
por: Xiong, Cui, et al.
Publicado: (2020)

Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
por: Worley, Joanna R, et al.
Publicado: (2007)

Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy and Mitochondrial Dysfunction
por: Mohammad, Ghulam, et al.
Publicado: (2010)

The Role of Matrix Metalloproteinases in Diabetic Wound Healing in relation to Photobiomodulation
por: Ayuk, Sandra Matabi, et al.
Publicado: (2016)

GH replacement causing acute hyperglycaemia and ketonuria in a type 1 diabetic patient
por: Cavlan, Dominic, et al.
Publicado: (2013)

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
por: Khunti, Kamlesh, et al.
Publicado: (2017)

Food insecurity, type 2 diabetes, and hyperglycaemia: A systematic review and meta‐analysis
por: Beltrán, Sourik, et al.
Publicado: (2021)

Early Recognition of Overweight Hyperglycaemia May Improve Clinical Outcomes in Type 2 Diabetes
por: Chockalingam, Anand, et al.
Publicado: (2023)

Effects of reduced β(2)-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice
por: Xu, Jun, et al.
Publicado: (2014)

Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
por: Wu, Wen-Chi, et al.
Publicado: (2020)

Management of postprandial hyperglycaemia and weight gain in women with gestational diabetes mellitus using a novel telemonitoring system
por: Al-ofi, Ebtisam A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3gbu86i0qaegr9bdu4b5p2hpoa